The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies

Abstract Bioequivalence (BE) studies are prerequisite in generic products approval. Normally, they are quite simple in design and expensive in execution, and sometimes suffer ethical questioning. Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model (GA‐RxODE)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ezequiel Omar Nuske, Mikhail Morozov, Héctor Alejandro Serra
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/0adb05e812fe4f52af49d0fafadfe106
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0adb05e812fe4f52af49d0fafadfe106
record_format dspace
spelling oai:doaj.org-article:0adb05e812fe4f52af49d0fafadfe1062021-11-16T13:45:54ZThe use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies2052-170710.1002/prp2.824https://doaj.org/article/0adb05e812fe4f52af49d0fafadfe1062021-10-01T00:00:00Zhttps://doi.org/10.1002/prp2.824https://doaj.org/toc/2052-1707Abstract Bioequivalence (BE) studies are prerequisite in generic products approval. Normally, they are quite simple in design and expensive in execution, and sometimes suffer ethical questioning. Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model (GA‐RxODE) is a multipurpose method used in pharmacokinetic (PK) optimization. It can be used to complete concentration–time (C–T) missing data. In this investigation, GA‐RxODE was applied in BE field. For this purpose, three BE studies were selected as a source data comprising formulations of metformin, alprazolam and clonazepam. From them, five blood samples values per volunteer‐round from specific preset times were chosen as if BE study was carried out with five instead of the classic 10–20 samples. With the five values of each volunteer a complete C–T curve was simulated by GA‐RxODE and certain PK estimation parameters (as maximum concentration, Cmax, and area under C–T curve from zero to infinite, AUCinf) were elicited. Finally, with these modeled parameters, a BE analysis was performed according to certain regulatory agencies guidances. Some results, expressed as geometric mean ratios of compared formulations and their 90% confidence intervals (CI90), were as follows: Metformin Cmax = 0.954 (0.878–1.035), AUCinf = 0.949 (0.881–1.022); Alprazolam Cmax = 1.063 (0.924–1.222), AUCinf = 1.036 (0.857–1.249), Clonazepam Cmax = 0.927 (0.831–1.034), and AUCinf = 1.021 (0.931–1.119). All CI90 were inside the 0.8–1.25 BE range. In summary, the simulated data were bioequivalent and non‐significantly different from original studies’ data. This raises the opportunity to perform more economic BE studies to build reliable PK estimation parameters from a few samples per volunteer.Ezequiel Omar NuskeMikhail MorozovHéctor Alejandro SerraWileyarticlebioequivalence studiesgeneric drugsgenetics algorithmsNLME modelspharmacokineticTherapeutics. PharmacologyRM1-950ENPharmacology Research & Perspectives, Vol 9, Iss 5, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic bioequivalence studies
generic drugs
genetics algorithms
NLME models
pharmacokinetic
Therapeutics. Pharmacology
RM1-950
spellingShingle bioequivalence studies
generic drugs
genetics algorithms
NLME models
pharmacokinetic
Therapeutics. Pharmacology
RM1-950
Ezequiel Omar Nuske
Mikhail Morozov
Héctor Alejandro Serra
The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies
description Abstract Bioequivalence (BE) studies are prerequisite in generic products approval. Normally, they are quite simple in design and expensive in execution, and sometimes suffer ethical questioning. Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model (GA‐RxODE) is a multipurpose method used in pharmacokinetic (PK) optimization. It can be used to complete concentration–time (C–T) missing data. In this investigation, GA‐RxODE was applied in BE field. For this purpose, three BE studies were selected as a source data comprising formulations of metformin, alprazolam and clonazepam. From them, five blood samples values per volunteer‐round from specific preset times were chosen as if BE study was carried out with five instead of the classic 10–20 samples. With the five values of each volunteer a complete C–T curve was simulated by GA‐RxODE and certain PK estimation parameters (as maximum concentration, Cmax, and area under C–T curve from zero to infinite, AUCinf) were elicited. Finally, with these modeled parameters, a BE analysis was performed according to certain regulatory agencies guidances. Some results, expressed as geometric mean ratios of compared formulations and their 90% confidence intervals (CI90), were as follows: Metformin Cmax = 0.954 (0.878–1.035), AUCinf = 0.949 (0.881–1.022); Alprazolam Cmax = 1.063 (0.924–1.222), AUCinf = 1.036 (0.857–1.249), Clonazepam Cmax = 0.927 (0.831–1.034), and AUCinf = 1.021 (0.931–1.119). All CI90 were inside the 0.8–1.25 BE range. In summary, the simulated data were bioequivalent and non‐significantly different from original studies’ data. This raises the opportunity to perform more economic BE studies to build reliable PK estimation parameters from a few samples per volunteer.
format article
author Ezequiel Omar Nuske
Mikhail Morozov
Héctor Alejandro Serra
author_facet Ezequiel Omar Nuske
Mikhail Morozov
Héctor Alejandro Serra
author_sort Ezequiel Omar Nuske
title The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies
title_short The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies
title_full The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies
title_fullStr The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies
title_full_unstemmed The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies
title_sort use of ga‐rxode (genetics algorithms and running simulations from ordinary differential equations‐based model) method to optimize bioequivalence studies
publisher Wiley
publishDate 2021
url https://doaj.org/article/0adb05e812fe4f52af49d0fafadfe106
work_keys_str_mv AT ezequielomarnuske theuseofgarxodegeneticsalgorithmsandrunningsimulationsfromordinarydifferentialequationsbasedmodelmethodtooptimizebioequivalencestudies
AT mikhailmorozov theuseofgarxodegeneticsalgorithmsandrunningsimulationsfromordinarydifferentialequationsbasedmodelmethodtooptimizebioequivalencestudies
AT hectoralejandroserra theuseofgarxodegeneticsalgorithmsandrunningsimulationsfromordinarydifferentialequationsbasedmodelmethodtooptimizebioequivalencestudies
AT ezequielomarnuske useofgarxodegeneticsalgorithmsandrunningsimulationsfromordinarydifferentialequationsbasedmodelmethodtooptimizebioequivalencestudies
AT mikhailmorozov useofgarxodegeneticsalgorithmsandrunningsimulationsfromordinarydifferentialequationsbasedmodelmethodtooptimizebioequivalencestudies
AT hectoralejandroserra useofgarxodegeneticsalgorithmsandrunningsimulationsfromordinarydifferentialequationsbasedmodelmethodtooptimizebioequivalencestudies
_version_ 1718426463407964160